CLEAR CREEK BIO, INC.
- Country
- ๐บ๐ธUnited States
- Ownership
- Private
- Established
- 2017-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.clearcreekbio.com
Clinical Trials
6
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (6 trials with phase data)โข Click on a phase to view related trials
Brequinar Combined With Dipyridamole in Patients With Mild to Moderate COVID-19
- Conditions
- COVID-19
- Interventions
- First Posted Date
- 2021-12-22
- Last Posted Date
- 2023-11-07
- Lead Sponsor
- Clear Creek Bio, Inc.
- Target Recruit Count
- 26
- Registration Number
- NCT05166876
- Locations
- ๐ฎ๐ณ
RIMS - Government Medical College, Srikakulam, Andhra Pradesh, India
๐ฎ๐ณKing George Hospital, Visakhapatnam, Andhra Pradesh, India
๐ฎ๐ณGlobal Hospital, Surat, Gujarat, India
CRISIS2: A Phase 2 Study of the Safety and Antiviral Activity of Brequinar in Non-hospitalized Pts With COVID-19
- First Posted Date
- 2020-10-05
- Last Posted Date
- 2022-04-19
- Lead Sponsor
- Clear Creek Bio, Inc.
- Target Recruit Count
- 115
- Registration Number
- NCT04575038
- Locations
- ๐บ๐ธ
Central Alabama Research, Homewood, Alabama, United States
๐บ๐ธArk Clinical Research, Long Beach, California, United States
๐บ๐ธDoral Medical Research, Doral, Florida, United States
Safety and Anti-coronavirus Response of Suppression of Host Nucleotide Synthesis in Patients With COVID-19
- First Posted Date
- 2020-06-11
- Last Posted Date
- 2022-02-17
- Lead Sponsor
- Clear Creek Bio, Inc.
- Target Recruit Count
- 25
- Registration Number
- NCT04425252
- Locations
- ๐บ๐ธ
Hartford Hospital, Hartford, Connecticut, United States
๐บ๐ธBaptist Medical Center, Jacksonville, Florida, United States
๐บ๐ธUniversity of South Florida/Tampa General, Tampa, Florida, United States
A Study of Brequinar in Subjects With Relapsed/Refractory Acute Myeloid Leukemia
- First Posted Date
- 2018-11-30
- Last Posted Date
- 2022-08-08
- Lead Sponsor
- Clear Creek Bio, Inc.
- Target Recruit Count
- 17
- Registration Number
- NCT03760666
- Locations
- ๐บ๐ธ
City of Hope, Duarte, California, United States
๐บ๐ธMassachusetts General Hospital, Boston, Massachusetts, United States
๐บ๐ธBeth-Israel Deaconess Medical Center, Boston, Massachusetts, United States